Vaxart, Inc. Increase (Decrease) in Deferred Income Taxes
Vaxart, Inc. (VXRT) reported Increase (Decrease) in Deferred Income Taxes of -$1.50 million for the 12-month period ending 2013-06-30, per its 10-K filed 2015-09-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2015-09-11
- Vaxart, Inc. increase (decrease) in deferred income taxes for the quarter ending 2013-06-30 was -$1.10M.
- Vaxart, Inc. increase (decrease) in deferred income taxes for the quarter ending 2013-03-31 was $0.00.
- Vaxart, Inc. increase (decrease) in deferred income taxes for the quarter ending 2012-12-31 was -$500.00K.
- Vaxart, Inc. increase (decrease) in deferred income taxes for the quarter ending 2012-09-30 was $100.00K.
- Vaxart, Inc. increase (decrease) in deferred income taxes for fiscal 2013 was -$1.50M, a 850.00% decline from fiscal 2012.
- Vaxart, Inc. increase (decrease) in deferred income taxes for fiscal 2012 was $200.00K.
- Vaxart, Inc. increase (decrease) in deferred income taxes for fiscal 2011 was -$400.00K.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 6 month as first filed | Increase (Decrease) in Deferred Income Taxes 9 month | Increase (Decrease) in Deferred Income Taxes 9 month as first filed | Increase (Decrease) in Deferred Income Taxes 12 month |
|---|---|---|---|---|---|---|
| 2013-06-30 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-11 | -$1.10M derived: sum of 2 quarters · filed 2015-09-11 | -$1.60M derived: sum of 3 quarters · filed 2015-09-11 | -$1.50M 10-K · filed 2015-09-11 | ||
| 2013-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | -$500.00K derived: sum of 2 quarters · filed 2014-05-12 | -$400.00K 10-Q · filed 2014-05-12 | -$414.00K 10-Q · filed 2013-05-10 | -$704.00K derived: sum of 4 quarters · filed 2014-09-30 | |
| 2012-12-31 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-10 | -$400.00K 10-Q · filed 2014-02-10 | -$390.00K 10-Q · filed 2013-02-11 | -$704.00K derived: sum of 3 quarters · filed 2014-09-30 | -$849.00K derived: sum of 4 quarters · filed 2014-09-30 | |
| 2012-09-30 | $100.00K 10-Q · filed 2013-11-12 | -$204.00K derived: sum of 2 quarters · filed 2014-09-30 | -$349.00K derived: sum of 3 quarters · filed 2014-09-30 | |||
| 2012-06-30 | -$304.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-30 | -$449.00K derived: sum of 2 quarters · filed 2014-09-30 | $200.00K 10-K · filed 2014-09-30 | |||
| 2012-03-31 | -$145.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-10 | $504.00K 10-Q · filed 2013-05-10 | ||||
| 2011-12-31 | $649.00K 10-Q · filed 2013-02-11 | |||||
| 2011-06-30 | -$400.00K 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |